InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Monday, 10/03/2016 10:50:50 PM

Monday, October 03, 2016 10:50:50 PM

Post# of 48316
REV 1 ON ONCOSEC:

REV·1 developed multiple design solutions addressing how to access the tumors, stabilize them, and deliver OncoSec's proprietary Genetic Payload, followed by electroporating the tumors.

REV·1 designed a simple hand-held unit that can be introduced in a minimally invasive out-patient setting to access tumors deep in the body. Currently in pre-clinical trials, this device, combined with OncoSec's proprietary gene therapy, will radically change the treatment of these deep-in-the-body, life-threatening tumors.

Oncosec will be a part of the immunotherapy revolution friends. Count on it.